FDA clears Merck's Keytruda based on cancer genetics, not location

(Reuters) - Merck& Co's immunotherapy Keytruda on Tuesday became the first cancer drug ever approved by the U.S. Food and Drug Administration based on a patients' specific genetic traits, regardless of where in the body the disease originated.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news